确保医疗和科研用途国际管制药物 充分供应的进展情况
2018 年理事會報告的補編
Abstract
The preamble of the Single Convention of 1961 highlights the concern of States for the health and welfare of humankind. This fundamental assertion is followed by the recognition of the medical use of narcotic drugs and their indispensable role in the relief of pain for which countries needed to ensure the availability and to make adequate provision. These principles were reaffirmed in the Convention on Psychotropic Substances of 1971 in which it was added that, while it was necessary to restrict the use of controlled substances to legitimate purposes, their availability should not have been unduly restricted. After almost sixty years since that official proclamation, the goal of ensuring availability is still elusive in many countries where people still suffer or die in pain or do not have access to the medications they need. The imbalance in the availability of opioid analgesics is particularly worrying as the data show that many of the conditions requiring pain management, particularly cancer, are prevalent and increasing in low- and middle-income countries.
Table of Contents
国际麻醉品管制局成员
致谢
内容提要
背景
制约麻醉药品和精神药物供应的因素
麻醉药品
精神药物
四.麻管局所提建议和2016年召幵的关于 世界毒品问题的大会特别会议成果文件 所载建议的落实情况
结论和前进道路


